ACE2 and COVID-19: These data demonstrated that ACE2 autoantibodies for all Ig subclasses could be detected, and individuals hospitalized with severe COVID-19 had higher levels of ACE2 autoantibodies after recovery compared to those that were healthy or had mild disease.